Pioglitazone Therapy in Patients With Stroke and Prediabetes A Post Hoc Analysis of the IRIS Randomized Clinical Trial
J David Spence, Catherine M Viscoli, Silvio E Inzucchi, Jennifer Dearborn-Tomazos, Gary A Ford, Mark Gorman, Karen L Furie, Anne M Lovejoy, Lawrence H Young, Walter N Kernan, Christopher Bladin, Stephen Davis, Tissa Wijeratne, Christopher Levi, Mark Parsons, Amy Brodtmann, Steven Ng, John Archer, Candice Delcourt, Toni R Winder Show all
JAMA Neurology | AMER MEDICAL ASSOC | Published : 2019
Awarded by National Institute of Neurological Disorders and Stroke
The IRIS trial was supported by a grant (U01NS044876) from the National Institute of Neurological Disorders and Stroke. Takeda Pharmaceuticals International Inc donated pioglitazone and matching placebo for the trial and had the right to a delay of up to 6 weeks before submission of the paper for patent purposes.